This summer US chip maker Qualcomm sued Chinese phone maker Meizu, claiming the company’s devices infringed on Qaulcomm’s patents for cellular communications.

Now the two companies have reached a settlement, with Meizu agreeing to pay Qualcomm patent fees.

The deal gives Meizu the right to sell phones around the world that use Qualcomm’s patented technology for 3G and 4G LTE modems.

As Bloomberg notes, the case is important not only because of what it means for the two companies involved, but also because it shows that a major US company was able to win an intellectual property case in China, a country that hasn’t always been known for rigorously protecting intellectual property, but where there there are more than a billion cellphones in use.

Qualcomm has licensing deals in place with a number of other major smartphone makers, and just this week announced a deal with Chinese phone maker Gionee.

via GizmoChina

Support Liliputing

Liliputing's primary sources of revenue are advertising and affiliate links (if you click the "Shop" button at the top of the page and buy something on Amazon, for example, we'll get a small commission).

But there are several ways you can support the site directly even if you're using an ad blocker* and hate online shopping.

Contribute to our Patreon campaign

or...

Contribute via PayPal

* If you are using an ad blocker like uBlock Origin and seeing a pop-up message at the bottom of the screen, we have a guide that may help you disable it.

Subscribe to Liliputing via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 9,543 other subscribers

2 replies on “Qualcomm and Meizu settle patent case”

  1. Does it mean we see Meizu phones with Snapdragon processors?
    Sure.

    Could it mean we’ll see Meizu phones sold in USA/UK/Europe/Australia/NZ ???
    Fat chance (ie no).

  2. I wonder if this is related to the billion dollar antitrust fine that China just gave Qualcomm. I am expecting that fine to be reduced now.

Comments are closed.